Parnell Pharmaceuticals Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Brad McCarthy
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.8yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
CEO
Brad McCarthy (48 yo)
14.8yrs
Tenure
Mr. Brad R. McCarthy, CPA, has been the Chief Financial Officer at Parnell Pharmaceuticals Holdings Ltd since February 2010 and serves as its Chief Executive Officer since January 9, 2018 and serves as its...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 18.8yrs | no data | no data | |
| Independent Director | 3.9yrs | no data | no data | |
| Independent Director | 3.9yrs | no data | no data | |
| Independent Director | 3.9yrs | no data | no data |
3.9yrs
Average Tenure
Experienced Board: PARN.F's board of directors are considered experienced (3.9 years average tenure).